🇺🇸 Romosozumab and Denosumab Combination Therapy in United States

Romosozumab and Denosumab Combination Therapy (Romosozumab and Denosumab Combination Therapy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Romosozumab and Denosumab Combination Therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Romosozumab and Denosumab Combination Therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Romosozumab and Denosumab Combination Therapy in United States?

Marmara University is the originator. The local marketing authorisation holder may differ — check the official source linked above.